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Homeostasis and regeneration of corneal epithelia are sustained by limbal epithelial stem cells (LESCs); thus, an LESC deﬁciency is
a major cause of blindness worldwide. Despite the generally promising results of cultivated LESC transplantation, it has been
limited by variations in long-term success rates, the use of xenogeneic and undeﬁned culture components, and a scarcity of
donor tissues. In this study, we identiﬁed the culture conditions required to expand LESCs in vitro and established human
limbus-derived highly proliferative ABCG2+/ABCB5+ double-positive LESCs. These LESCs exhibited the LESC marker proﬁle
and diﬀerentiated into corneal epithelial cells. In addition, cultured LESCs expressed high levels of the stem cell markers Sox2,
Oct4, c-Myc, and Klf4, had high telomerase activity, and had stable, normal genomes. These results suggest that our novel
cultivation protocol aﬀects the phenotype and diﬀerentiation capacity of LESCs. From the limbus, which contains a
heterogenous cell population, we have derived highly proliferative ABCG2+/ABCB5+ double-positive cells with the ability to
diﬀerentiate into corneal epithelial cells. This study opens a new avenue for investigation of the molecular mechanism of LESC
maintenance and expansion in vitro and may impact the treatment of corneal disease, particularly corneal blindness due to an
LESC deﬁciency.
1. Introduction
A surgical strategy for restoring the corneal epithelial surface
in patients that lack suﬃcient limbal epithelial stem cells
(LESCs) is the transplantation of ex vivo expanded LESCs,
which is one of the few adult human stem cell therapies cur-
rently being used [1–4]. This therapeutic approach typically
involves harvesting a small limbal sample from the patient
or a donor followed by cell expansion to generate an epithe-
lial sheet on a transplantable carrier, such as an amniotic
membrane [5–10], ﬁbrin gel, or temperature-responsive
polymer [11]. Although successful repopulation of the ocular
surface has been described for up to 1 year after transplanta-
tion, studies have indicated that epithelial viability is not sus-
tained for very long [12] and that donor cells do not survive
more than 9 months after transplantation [13, 14]. These
failures may have resulted from depletion of LESCs in culture
due to improper culture conditions. Most culture methods,
including explant and airlift cultures, promote the prolifera-
tion and terminal diﬀerentiation of transient amplifying cells
(TACs) rather than retaining LESCs [15]. However, long-
term restoration of the damaged ocular surface requires
the preservation of LESCs during culture and after grafting
[4, 16]. Since the pioneering work in 1975 by Rheinwald and
Green [17], studies have shown that long-term survival and
serial expansion of LESCs are possible if they are cocultured
with ﬁbroblast feeder cells [18]. Three types of clonogenic
cells, which give rise to holoclones, meroclones, and para-
clones, were identiﬁed by clonal analysis of human keratino-
cytes cultured on feeder layers [19]. Holoclone-forming cells
have all of the hallmarks of LESCs, including the capacity to
self-renew and a high potential to proliferate, whereas
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meroclones and paraclones are generated by diﬀerent stages
of TACs and have limited capacities for proliferation. This
discovery was followed by the identiﬁcation of holoclone-
forming cells in the limbal epithelium and the development
of a culture system that enriches for LESCs by growing them
clonally on feeder layers before seeding them onto ﬁbrin gels
to produce epithelial sheets [20, 21]. Consistently, keratino-
cytes cultured by this method have been used to restore
massive epidermal defects permanently and to restore the
corneal surface of patients with complete LESC deﬁciencies
[1, 22–24]. Nevertheless, the question of whether the trans-
planted cell sheets actually contain LESCs has not been
addressed and the widespread use of this promising cultiva-
tion technique has been hampered by the lack of a standard-
ized cultivation protocol.
In this study, we evaluated the eﬀects of several culture
variables on the growth and retention of LESCs in culture
to develop an optimal cultivation protocol that promotes
the expansion and maintenance of LESCs for therapeutic
applications. We developed a culture method to establish
human limbus-derived, highly proliferative ABCG2+/
ABCB5+ double-positive LESC cultures. The LESCs that we
cultured by this method were conﬁrmed to have the LESC
marker proﬁle and exhibited the potential to diﬀerentiate
into corneal epithelial cells. Moreover, these LESCs expressed
high levels of stem cell markers, including Sox2, Oct4, c-Myc,
and Klf4 [25, 26], displayed high telomerase activity, and had
stable, normal genomes. Using the limbus, which contains a
heterogenous cell population, as a cell source and our speciﬁc
culture conditions, we were able to establish a novel and
highly proliferative ABCG2+/ABCB5+ double-positive stem
cell population with the capacity for corneal epithelial diﬀer-
entiation. Thus, our proposed culture systemmay be essential
for the long-term clinical success and stable regeneration
of corneal epithelia to treat corneal blindness due to an
LESC deﬁciency.
2. Materials and Methods
2.1. Cell Culture and Establishment of ABCG2+/ABCB5+
Double-Positive LESCs. Human corneal tissues were har-
vested from healthy corneas that were deposited in an eye
bank after penetrating or lamellar keratoplasty. Donor conﬁ-
dentiality was maintained in accordance with the Declaration
of Helsinki, and the research protocol below was approved
by the Severance Hospital IRB Committee (CR04124) of
Yonsei University.
(1) Within 4 hours after penetrating keratoplasty, fresh
corneoscleral rim tissue was placed in a 60mm cul-
ture dish containing Hank’s Balanced Salt Solution
(HBSS) and was cut into four equal segments of the
limbus (limbus portion including the small cornea
region). Any remaining iris and endothelial cells were
rubbed oﬀ with a cotton tip.
(2) Each segment was digested with 15mg/mL of dispase
II (Roche, Rotkreuz, Switzerland) in supplemented
hormonal epithelial media (SHEM; CELLnTEC
Advanced Cell Systems AG, Bern, Switzerland) with
100mM sorbitol (Sigma-Aldrich, St Louis, MO) at
4°C for 18 h to separate the stroma from the rest of
the tissue.
(3) Under a dissecting microscope, an already loose
limbal epithelial sheet was separated from the tissue
by inserting and sliding a noncutting ﬂat stainless
steel spatula into the plane between the limbal epithe-
lium and the stroma.
(4) The isolated limbal epithelial cell (LECs) clusters were
seeded onto a 60mm plate coated with 5% Matrigel
(BD Biosciences, Bedford, MA) and 0.05mg/ml
human ﬁbronectin (Sigma-Aldrich, St. Louis, MO)
and cultured in CnT20 medium (CELLnTEC
Advanced Cell Systems AG, Bern, Switzerland).
(5) After 3 days, the LECs were cultured in 10% fetal
bovine serum (FBS) Dulbecco’s Modiﬁed Eagle
Medium (DMEM; Invitrogen, Carlsbad, CA), and
the medium was changed every 2 days.
(6) After 8–10 days, highly proliferative cell colonies
appeared in the culture plates.
(7) Highly proliferative cell colonies were washed with
PBS two times and treated with 1mL Accutase
(Sigma-Aldrich, St. Louis, MO), prewarmed at 37°C,
and shaken evenly 5-6 times. The Accutase was then
discarded, and cells were treated again with 1mL
Accutase and shaken evenly 4-5 times. Accutase was
then discarded again, and cells were incubated for
3–5min at 37°C in an incubator. Colonies were
digested separately. Single cells were seeded onto
plates coated with a matrix of Matrigel and ﬁbronec-
tin and cultured in DMEM containing 10% FBS. The
highly proliferative cells that attached to the new
plate were designated limbal epithelial stem cells
(LESCs).
(8) After 48 hours, The LESCs were treated with Accu-
tase and sorted by FACS analysis using ABCG2+ anti-
bodies (Abcam, Cambridge, MA) and ABCB5+
antibodies (Thermo ﬁsher scientiﬁc, Rockford, IL).
(9) The ABCG2+/ABCB5+ double-positive cells were
seeded onto a plate coated with a matrix of Matrigel
and ﬁbronectin and cultured in 10% FBS DMEM.
When the plate was full of cells, the cells were treated
with Accutase and seeded onto a plate coated with a
matrix of Matrigel and ﬁbronectin and cultured in
10% FBS DMEM. Then, the ABCG2+/ABCB5+
double-positive cells were cultured using mass cul-
ture methods and were named ABCG2+/ABCB5+
double-positive LESCs.
2.2. Real-Time Quantitative Reverse Transcriptase PCR
(Real-Time qRT-PCR). Total RNA was isolated from corneal
epithelial cells diﬀerentiated from ABCG2+/ABCB5+ LESCs
with TRIzol reagent (Invitrogen, Carlsbad, CA). mRNA
expression of human GAPDH, Δnp63α, ABCG2, CK3,
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CK19, Integrin α9, CK12, OCT4, SOX2, NANOG, c-MYC,
and KLF4 was measured using the Power SYBR Green
RNA-to-CT™ 1-Step kit (Applied Biosystems, Foster City,
CA, USA) and StepOnePlus™ (Applied Biosystems) accord-
ing to the manufacturer’s instructions. The PCR protocol
was 48°C for 30min, 95°C for 10min, 40 cycles of 95°C
for 15 s, and 60°C for 1min. Expression results were based
on cycle threshold (Ct) values. The diﬀerences between
the Ct values for the experimental genes and the reference
gene GAPDH were calculated and graphed as ratios of
experimental RNAs to the calibrated sample. The primers
used for gene ampliﬁcation are listed in Supporting Infor-
mation Table S1 available online at https://doi.org/10.
1155/2017/7678637. Three independent experiments were
performed, and statistical analysis was carried out using
the Newman-Keuls multiple comparison test.
2.3. Immunoﬂuorescence Staining. Cells were ﬁxed in 3.7%
formaldehyde for 20min, permeabilized with 0.1% Triton
X-100 in phosphate buﬀered saline (PBS), and preincubated
in a blocking solution of PBS containing 5% normal donkey
serum and 0.05% Tween-20. Then, cells were incubated with
primary antibody for 2 h at room temperature. The primary
antibodies used included anti-human p63α antibody (Cell
Signaling, Beverly, MA), anti-human ABCG2 antibody
(Abcam, Cambridge, England), anti-human ABCB5 anti-
body (Invitrogen, Carlsbad, CA), anti-human CK19 antibody
(Abcam, Cambridge, England), anti-human CK3 antibody
(Abcam, Cambridge, England), and anti-human desmoglein
3 antibody (Novus Biologicals, Littleton, Co.). Then, cells
were labeled with a ﬂuorescein-conjugated secondary anti-
body (Molecular Probes, Eugene, OR) and nuclei were coun-
terstained with 4′6-diamidino-2-phenylindole (DAPI).
Samples were observed with a ﬂuorescence microscope
(Olympus, Tokyo, Japan).
2.4. Diﬀerentiation of LESCs into Corneal Epithelial Cells.
ABCG2+/ABCB5+ LESCs were seeded in a 12-well plate at
a density of 3× 104 cells per well and cultured in 10% FBS
DMEM. At 90% cell conﬂuence, DMEM was replaced with
CnT30 medium (CELLnTEC Advanced Cell Systems AG).
Negative control cultures were maintained in 10% FBS
DMEM. Culture media was changed every 2 days for 5 days,
and then the cells were ﬁxed in 3.7% formaldehyde and
immunostained with the appropriate antibodies.
2.5. Diﬀerentiation of LESCs into Corneal Epithelial Cells on
Transwell Filters. ABCG2+/ABCB5+ LESCs (1× 105) were
seeded onto 0.4 μm 12-well transwell ﬁlters in 10% FBS
DMEM. At 90% cell conﬂuence, DMEM was replaced with
CnT30 medium. Negative control cultures were maintained
in 10% FBS DMEM. Cell diﬀerentiation was performed
under immersed conditions. Culture media was changed
every 2 days for 5 days, and then the cells were ﬁxed
in 3.7% formaldehyde and immunostained with the
appropriate antibodies.
After 6 days, the transwell ﬁlters were ﬁxed in 3.7% form-
aldehyde, embedded into paraﬃn, and sliced into 8 μm-thick
sections. The sections were washed in PBS, blocked in 5%
normal donkey serum and 0.1% Triton X-100, and incubated
overnight in primary antibody 2h at room temperature. The
primary antibodies included anti-human p63α (Cell Signal-
ing), anti-human ABCG2 (Abcam), anti-human ABCB5
(Invitrogen), anti-human CK3 (Abcam), and anti-human
desmoglein 3 (Novus Biologicals). Then, the sections were
labeled with a ﬂuorescein-conjugated secondary antibody
(Molecular Probes), and nuclei were counterstained with
DAPI. Samples were observed with a ﬂuorescence micro-
scope (Olympus, Tokyo, Japan).
2.6. Diﬀerentiation of LESCs into Corneal Epithelial Cells on
Amniotic Membranes. A total of 1× 105 LESCs were seeded
on a 60mm plate and infected with GFP+ lentivirus
(MOI= 10) for 16h. After 24h, the transduction eﬃciency
was evaluated based on the number of GFP-positive LESCs
scored under a ﬂuorescence microscope. Under these condi-
tions, the transduction eﬃciency was 35%± 1.2%. However,
to acquire pure GFP+ LESCs, LESCs were selected with puro-
mycin (lentiviral vector containing the puromycin selection
marker). Thus, we used pure GFP+ LESCs in this experiment.
We also compared the proliferation and diﬀerentiation eﬃ-
ciency of LESCs infected with no lentivirus, GFP-negative
lentivirus, or GFP-positive lentivirus. However, we did not
ﬁnd any signiﬁcant diﬀerences in proliferation or diﬀerentia-
tion of LESCs under each condition.
GFP lentivirus-infected ABCG2+/ABCB5+ LESCs
(1× 105) were seeded onto 1 cm2 human amniotic mem-
branes in 10% FBS DMEM. After 3 days, DMEM was
replaced with CnT30 medium (CELLnTEC Advanced Cell
Systems AG). Culture media was changed every 2 days for
10 days. Amniotic membranes were ﬁxed in 3.7% formalde-
hyde and immunostained with the appropriate antibodies.
2.7. Growth Assay. For serial propagations, ABCG2+/
ABCB5+ LESCs and primary LECs were seeded at densities
of 4× 104 cells per well on 12-well plates coated with a matrix
of Matrigel and ﬁbronectin. After 2 days, cells were conﬂuent
and passaged to new plates at a 1 : 3 ratio, which allowed cells
to achieve conﬂuence within 2 more days. Cells were pas-
saged every 2 days for 92 days.
2.8. Telomerase Activity Assay. Telomerase activity in LESCs
and LECs was analyzed with the TRAPEZE® Telomerase
Detection Kit (S7700-KIT; Millipore Company, Purchase,
NY) according to the manufacturer’s instructions. In brief,
a cell pellet containing 500–1000 cells was resuspended in
50 μL of 1X CHAPS lysis buﬀer, incubated on ice for
30min, and centrifuged. Then, 5 μL of the supernatant was
transferred into a fresh tube and incubated with 5 μL of mas-
ter mix A, which consisted of TRAP buﬀer (20mM Tris-HCl,
pH8.3, 1.5mM MgCl2, 63mM KCl, 0.05% (v/v) Tween 20,
1mM EDTA, and 0.01% BSA; TRAPEZE Telomerase Detec-
tion Kit), dNTPs, TS primer, and dH2O. The reaction was
incubated at 30°C for 30min, at 94°C for 1min, and then kept
on ice. Then, 10 μL of master mix C (TRAP buﬀer, 0.01%
BSA, ACX primer, Taq polymerase, 15% glycerol, SYBR
green, and dH2O) was added, and PCR was performed in a
thermocycler (Applied Biosystems Veriti Thermal Cycler;
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ABI) as follows: 94°C for 2min and 40 cycles of 94°C for 10 s,
50°C for 5 s, and 72°C for 10 s. The diﬀerences between the Ct
values for the LESCs and LECs were calculated and graphed.
2.9. Metaphase Chromosome Spread Assay. Cells were
arrested in metaphase by incubation in culture media with
0.05 μg/ml colcemid (ﬁnal concentration) for 1 h. The cell
suspensions were then treated with 75mM KCl for 30min
at room temperature and ﬁxed with Carnoy’s solution (3 : 1
methanol : acetic acid, v/v). To form chromosome spreads,
cell suspensions were dropped onto glass slides, air-dried,
and stained with DAPI. Images were obtained by ﬂuores-
cence microscopy. Twenty cells were analyzed in each group.
2.10. Flow Cytometric Analysis of the Cell Cycle. For analysis
of DNA content, 1× 105 cells were harvested, washed with
PBS, resuspended in 2ml of an ice-cold 70% ethanol and
30% PBS solution, and incubated on ice for 30min. Cells
were then harvested by centrifugation and stained with
15 μg/mL propidium iodide in PBS with 0.1mg/mL RNase
A for 30min at 37°C. At least 10,000 cells were acquired
per sample. Data were collected with CellQuest™ software
and analyzed with ModFitLT.
2.11. Clonal Analysis. Clonal expansion of ABCG2+/ABCB5+
LESCs was performed by seeding a single-cell suspension at
1× 103 cells/cm2 on a plate coated with a matrix of Matrigel
and ﬁbronectin and culturing cells in 10% FBS DMEM. Cul-
ture media was changed every 2 days, and colony formation
was monitored daily by phase contrast microscopy. Cells
were ﬁxed in 3.7% formaldehyde and immunostained with
the appropriate antibodies 8 days after seeding.
2.12. Statistical Analysis. All of the experiments were
repeated at least three times. Data were expressed as mean
± standard error, and statistical comparisons between groups
were performed by one-way ANOVA followed by the
Tukey’s test.
3. Results
3.1. Establishment of Highly Proliferative LESC Cultures. To
obtain highly proliferative and marker-speciﬁc pure LESCs,
we cultured human-derived LECs in various conditions.
Matrigel has been used as an extracellular matrix for cultur-
ing LESCs [27], but Matrigel alone is not suﬃcient to culture
LESCs. Fibronectin has also been used to culture various
stem cells [28–31]. In our study, we used Matrigel, ﬁbronec-
tin, and a mixture of Matrigel and ﬁbronectin as extracellular
matrices for culturing LESCs. Furthermore, LESCs have been
shown to maintain their stemness in cultures without serum,
but in a medium with serum, LESCs diﬀerentiated into cor-
neal epithelial cells [32]. We cultured LECs in CnT20
medium without serum and in 10% serum DMEM. A Matri-
gel or ﬁbronectin matrix alone did not lead to the formation
of colonies in CnT20 or in 10% serum DMEM (Supplemen-
tary Figure S1). However, highly proliferative colonies
formed when a mixture of Matrigel and ﬁbronectin was used
as the matrix and when cultured for over 15 days in 10%
serum DMEM (Supplementary Figure S1). To reduce the
culture time and to increase the numbers of highly prolifera-
tive colonies, isolated LECs were seeded onto a plate coated
with a mixture of Matrigel and ﬁbronectin and cultured in
CnT20 for 3 days. Then, the medium was replaced with
10% serum DMEM and changed every 2 days and cells were
cultured for 9 days. For 9 days, medium was changed every 2
days, but cells were not passaged. During the 9 days, small
colonies appeared on the plates and grew large. Among the
various colony morphologies, we observed fast-growing,
multilayered LESC-like colonies (Figure 1(a)).
ABCG2 and ABCB5 are known LESC markers [33, 34].
To increase the purity of the LESCs, we labeled them with
antibodies to ABCG2 and ABCB5 and performed FACS
analysis (Figure 1(b)). The cells isolated by FACS had the
high proliferation phenotype (Figure 1(b)), and we named
these cells ABCG2+/ABCB5+ double-positive LESCs. Our
results demonstrate that we identiﬁed the speciﬁc culture
conditions required to isolate and expand marker-speciﬁc
LESCs in vitro.
3.2. Marker Analysis of LESCs and Diﬀerentiation of
ABCG2+/ABCB5+ LESCs into Corneal Epithelial Cells. To
characterize the established ABCG2+/ABCB5+ LESCs, we
analyzed their marker expression proﬁles by RT-qPCR and
immunostaining. ABCG2+/ABCB5+ LESCs expressed LESC
marker CK19, p63α, ABCG2, and integrin α9 [35–37]
mRNAs when cultured in 10% serum DMEM (Figure 2(a)).
Immunostaining also showed expression of p63α, ABCG2,
and CK19 in ABCG2+/ABCB5+ LESCs (Figure 2(b)). When
ABCG2+/ABCB5+ LESCs were cultured in diﬀerentiation
media CnT20 and CnT30, expression of the stem cell
markers CK19, p63α, ABCG2, and integrin α9 decreased
(Figure 2(a)). In contrast, expression of the corneal epithelial
cell markers CK3 and CK12 increased when ABCG2+/
ABCB5+ LESCs were cultured in CnT20 and CnT30
(Figure 2(c)). These results demonstrate that ABCG2+/
ABCB5+ LESCs express LESC-speciﬁc markers and diﬀeren-
tiate into corneal epithelial cells.
3.3. Diﬀerentiation of LESCs into Corneal Epithelial Cells on
Transwell Filters and Amniotic Membranes. LESCs have the
potential to diﬀerentiate into corneal epithelial cells in vitro
and in vivo [37–39]. To conﬁrm the potential of ABCG2+/
ABCB5+ LESCs to diﬀerentiate into corneal epithelial cells,
we seeded ABCG2+/ABCB5+ LESCs in 12-well plates and
changed the DMEM medium to CnT30 medium. When cul-
tured in 10% serum DMEM, ABCG2+/ABCB5+ LESCs
expressed the stem cell-speciﬁc markers ABCG2 and P63α,
but when cultured in CnT30, P63α expression decreased
and expression of the corneal epithelial cell marker CK3
increased (Figure 3(a)). Furthermore, we developed a new
diﬀerentiation system that mimics in vivo diﬀerentiation
conditions. The cornea consists of ﬁve layered cell in our
body, and limbal LESCs move to the cornea and diﬀerentiate
into corneal epithelial cells [39, 40]. To mimic in vivo condi-
tions, we seeded ABCG2+/ABCB5+ LESCs onto 12-well
transwell ﬁlters and cultured them in 10% serum DMEM or
CnT30 for 5 days. For 5 days, medium was changed every 2
days, but cells were not passaged. Under these conditions,
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cells displayed multilayer growth without cell death.
ABCG2+/ABCB5+ LESCs cultured on transwell ﬁlters in
10% serum DMEM displayed multilayer cell growth and
expressed the stem cell markers ABCG2 and P63α. However,
expression of stem cell markers decreased and expression of
the corneal epithelial cell marker CK3 increased ABCG2+/
ABCB5+ LESCs cultured on transwell ﬁlters in CnT30
(Figure 3(b)). To analyze the transwell-cultured ABCG2+/
ABCB5+ LESCs in detail, transwell-cultured ABCG2+/
ABCB5+ LESCs were embedded in paraﬃn and were stained
immunohistochemically. Immunohistochemistry showed
that the multilayered cell growth of ABCG2+/ABCB5+ LESCs
on transwell ﬁlters resembles the cornea in vivo (Figure 4(a)).
In addition, immunostaining showed that ABCG2+/ABCB5+
LESCs on transwell ﬁlters expressed the stem cell markers
ABCG2, ABCB5, and P63α when cultured in 10% serum
DMEM and expressed the corneal epithelial cell markers
CK3 and desmoglein 3 and when cultured in CnT30
(Figures 4(b) and 5). Finally, we evaluated the diﬀerentiation
potential of ABCG2+/ABCB5+ LESCs on amniotic mem-
branes. GFP lentivirus-infected LESCs were seeded onto
amniotic membranes and cultured for 10 days in CnT30,
and they diﬀerentiated into corneal epithelial cells and
expressed the corneal epithelial cell marker CK3 (Figure 6).
Collectively, our results suggest that ABCG2+/ABCB5+
LESCs can diﬀerentiate into corneal epithelial cells and that
our newly developed diﬀerentiation system can mimic
in vivo diﬀerentiation and can be used to analyze the diﬀeren-
tiation potential of LESCs.
3.4. Stem Cell Potential of LESCs. To evaluate the stem cell
potential of the ABCG2+/ABCB5+ LESCs, we analyzed the
growth of LECs and ABCG2+/ABCB5+ LESCs. LECs were
cultured for approximately 15 days and passaged 3 times.
After this time, LEC proliferation decreased and growth
stopped after 30 days and 5 passages (Figure 7(a)). In con-
trast, ABCG2+/ABCB5+ LESCs showed continuous growth
over 90 days and 50 passages (Figure 7(a)). Phase contrast
image shows the maintenance of LESCs (Figure 7(a)). Fur-
thermore, because telomerase activity is associated with cell
proliferation in cultured cells [41] and in some stem cells
[42], we examined telomerase activity in ABCG2+/ABCB5+
DMEM + serum 10%CnT20
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Figure 1: Establishment of limbus-derived highly proliferative LESCs. (a) Cultivation of highly proliferative LESCs from limbal epithelial
cells. (b) Isolation of ABCG2+/ABCB5+ double-positive LESCs. Scale bars = 500 μm, 200 μm, and 100 μm.
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LESCs and found high telomerase activity (Figure 7(b)).
However, telomerase activity was not detected in primary
LECs (Figure 7(b)). After culturing ABCG2+/ABCB5+ LESCs
for 90 days, metaphase chromosome spread analysis was per-
formed to detect chromosome instabilities. The chromosome
spread assay has the powerful ability to analyze individual
cells for genome aberrations, including insertions, deletions,
and rearrangements involving one or more chromosomes
[43]. No genomic insertions, deletion, or rearrangements
were detected in ABCG2+/ABCB5+ LESCs; however, genetic
abnormalities were detected in SW620 colon cancer cells
(Figure 7(c)). In addition, cell cycle analysis by ﬂow
cytometry showed an increase in the S-phase of ABCG2+/
ABCB5+ LESCs, which has also been seen in some stem
cells, but the cell cycle of LECs was found to be normal
(Figure 7(d)).
Some stem cells express core transcription factors, such
as Oct4, Sox2, Nanog, c-Myc, and Klf4 [44–46]. To assess
expression of core transcription factors in ABCG2+/ABCB5+
LESCs, we isolated mRNA from ABCG2+/ABCB5+ LESCs
cultured in diﬀerent conditions and performed RT-qPCR.
ABCG2+/ABCB5+ LESCs expressed Oct4, Sox2, c-Myc,
and Klf4 mRNAs when cultured in 10% serum DMEM,
but expression of these markers decreased when the cells
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Figure 2: Marker analysis of ABCG2+/ABCB5+ LESCs. (a, c) Total mRNA was isolated from ABCG2+/ABCB5+ LESCs cultured in
10% DMEM, CnT20, or CnT30, and gene expression was assessed by RT-PCR. ∗∗p < 0 01 versus DMEM (b) ABCG2+/ABCB5+
LESCs were immunoﬂuorescently stained with antibodies to p63α, ABCG2, and CK19. Scale bar = 50 μm. w/o Ab: without primary
antibody + secondary antibody.
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were cultured in CnT20 or CnT30 diﬀerentiation media
(Supplementary Figure S2). To further elucidate the stem
cell character of ABCG2+/ABCB5+ LESCs, we examined
the colony-forming activity of ABCG2+/ABCB5+ LESCs.
Immunostaining showed strong colony formation by
ABCG2+/ABCB5+ LESCs (Supplementary Figure S3) indi-
cating that ABCG2+/ABCB5+ LESCs have signiﬁcant stem
cell activity and may be used to regenerate corneal epithelia.
Moreover, ABCG2+/ABCB5+ LESCs may be multipotent
and may be able to diﬀerentiate into other cell lineages in
addition to corneal epithelial cells.
4. Discussion
Many researchers have attempted to retain LESCs in culture,
but have been unsuccessful. Since the pioneering work in
1975 by Rheinwald and Green [17], studies have shown that
long-term survival and serial expansion of LESCs are possible
if they are cocultured with ﬁbroblast feeder cells. Neverthe-
less, the question of whether the transplanted cell sheets
actually contain LESCs has not been addressed and the wide-
spread use of this promising cultivation technique has been
hampered by the lack of a standardized cultivation protocol.
To expand cells and generate epithelial sheets, ﬁbrin gels,
temperature-responsive polymers, and amniotic membranes
have been used [11], but epithelial cell viability was not sus-
tained for very long [12], and no donor cells survived 9
months after transplantation [13, 14]. These failures may
have resulted from depletion of LESCs in culture due to
improper culture conditions. Rather than favoring retention
of LESCs, most culture methods promote the proliferation
and terminal diﬀerentiation of transient amplifying cells
(TACs) [15]. Long-term restoration of damaged ocular sur-
faces requires retention of a suﬃcient amount of LESCs dur-
ing culturing and after grafting [4, 16] to ensuring successful
regeneration of the ocular surface [47, 48].
In this study, we developed an optimal method to expand
and increase the survival and proliferation of LESCs derived
from a small limbal biopsy. Matrigel and ﬁbronectin were
used as matrices for culturing LESCs and other stem cells
[27–31], but Matrigel or ﬁbronectin alone is not suﬃcient
to culture LESCs. In this study, highly proliferative LESC
colonies formed when we used a mixture of Matrigel and
ﬁbronectin as the extracellular matrix.
LESCs are located in the basal region of the limbus and
require a speciﬁc environment for survival and growth. To
mimic the in vivo environment, we used various extracellular
matrix components (Matrigel, collagen, gelatin, ﬁbronectin,
ﬁbrin, etc.) for the in vitro culture of LESCs. However, we
did not identify the optimal conditions for LESC culture.
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Figure 3: Diﬀerentiation of ABCG2+/ABCB5+ LESCs into corneal epithelial cells. (a) ABCG2+/ABCB5+ LESCs were cultured in 10% DMEM
or CnT30 and stained with cell-speciﬁc markers. (b) ABCG2+/ABCB5+ LESCs were cultured on transwell ﬁlters in 10%DMEM or CnT30 and
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Matrigel has been used as an extracellular matrix for cultur-
ing LESCs [27]. However, Matrigel alone is not suﬃcient
for the culture of LESCs under our conditions. We have
had much experience in the culture of many types of stem
cells (mesenchymal stem cells, endothelial stem cells, neuro-
nal stem cells, embryonic stem cells, etc.) and have found that
ﬁbronectin has good eﬀects on stem cell proliferation. There-
fore, we mixed Matrigel and ﬁbronectin, and highly prolifer-
ative LESC colonies formed when we used this mixture as the
extracellular matrix. Other combinations of extracellular
matrix components did not yield suﬃcient LESC culture.
These results suggested that stimulation by ﬁbronectin may
recover the signal required for LESC growth, which could
not be obtained by Matrigel alone.
In addition, LESCs are known to maintain their stemness
in a medium without serum, but a medium with serum
induces diﬀerentiation of LESCs into corneal epithelial cells
[32]. We cultured LECs in CnT20 medium without serum
and in 10% serum DMEM without extracellular matrices
and did not observe highly proliferative cell phenotypes.
However, highly proliferative cell colonies formed when
LECs were cultured with a matrix of Matrigel and ﬁbronectin
in 10% serum DMEM indicating that speciﬁc culture condi-
tions, including the compositions of the extracellular matrix
and the cell culture medium, are required for eﬃcient growth
of undiﬀerentiated LESCs. In this study, we demonstrated
that corneal LESCs can be consistently expanded in vitro
using a mixed extracellular matrix and a medium containing
serum. Meyer-Blazejewska et al. proposed an improved cul-
ture protocol in 2010 [37]. There are three major diﬀerences
between our method and the method of Meyer-Blazejewska
et al. First, we cultured the cells on a mixture of Matrigel
and ﬁbronectin, whereas they cultured the cells on a 3T3
feeder cell layer. Second, we used CnT20 and DMEM con-
taining 10% serum, whereas they used MCDM151, Epilife,
DMEM/F12, PCT, or D-KSFM with several growth factors.
Third, we used transwell ﬁlters and amniotic membranes
for in vitro diﬀerentiation, whereas they used ﬁbrin gel. Most
importantly, the clonal growth phenotype was very diﬀerent.
Under our conditions, LESCs showed rapid growth and
multilayered colonies on the plates. However, they showed
only monolayer colonies. Collectively, these results suggested
that our method for cultivation of ABCG2+/ABCB5+ LESCs
was diﬀerent from that of Meyer-Blazejewska et al. and that
our established LESCs exhibited diﬀerent characteristics,
although some markers were similar.
The isolated and cultured ABCG2+/ABCB5+ LESCs
retained their viability and stemness as conﬁrmed by the
presence of the stem cell markers CK19, p63α, ABCG2, and
integrin α9. We conﬁrmed in vitro diﬀerentiation of LESCs
into corneal epithelial cells by the presence of the markers
CK12, CK3, and desmoglein3. These results suggest that
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Figure 6: Diﬀerentiation of ABCG2+/ABCB5+ LESCs into corneal epithelial cells on an amniotic membrane. GFP-positive ABCG2+/ABCB5+
LESCs were cultured on an amniotic membrane and were stained with antibodies to CK3. Scale bar = 200 μm.
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ABCG2+/ABCB5+ LESCs express LESC-speciﬁc markers and
can diﬀerentiate into corneal epithelial cells. Moreover, our
newly developed transwell ﬁlter diﬀerentiation system
mimics in vivo diﬀerentiation and may be used to analyze
the diﬀerentiation potential of LESCs in vivo.
The ABCG2+/ABCB5+ LESCs that we established dis-
played powerful stem cell activity, continuous growth, and
high telomerase activity without chromosome instability. In
addition, cell cycle analysis by ﬂow cytometry showed that
the S-phase of ABCG2+/ABCB5+ LESCs increased, which
has been observed in other stem cells, but the cell cycle of
LECs remained normal. In general, fate-determined normal
cells (limbal epithelial cells, ﬁbroblasts, endothelial cells, skin
epithelial cells, etc.) exhibited a slow cell cycle, and about 20–
30% of cells were in the S-phase, similar to LECs. However,
stem cells (mesenchymal stem cells, embryonic stem cells,
etc.) showed a rapid cell cycle and increased percentage of
cells in the S-phase (over 50% of cells were in the S-phase).
ABCG2+/ABCB5+ LESCs grew very rapidly and showed an
increase in the proportion of cells in the S-phase (over 50%
of cells were in the S-phase), similar to other stem cells.
Therefore, we suggested that ABCG2+/ABCB5+ LESCs had
stem cell characteristics.
Moreover, ABCG2+/ABCB5+ LESCs expressed the core
transcription factors Oct4, Sox2, c-Myc, and Klf4, which
are also expressed in multipotent stem cells. These data indi-
cate that the ABCG2+/ABCB5+ LESCs that we established
have powerful stem cell activity and may be used to regener-
ate corneal epithelia. Moreover, ABCG2+/ABCB5+ LESCs
may be multipotent and may be able to diﬀerentiate into
additional cell lineages.
In conclusion, our results show that with the appropri-
ate methods, including the appropriate matrix and medium,
human limbus-derived, highly proliferative ABCG2+/
ABCB5+ double-positive LESCs can be cultured. The
cultured LESCs exhibited the LESC marker proﬁle and the
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Figure 7: ABCG2+/ABCB5+ LESCs are potent stem cells. (a) Growth analysis of LESCs and LECs. (b) Telomerase activity in
ABCG2+/ABCB5+ LESCs and in LECs (500, 1000 cells) was measured by TRAP assay. ∗∗p < 0 01 versus LEC (c) metaphase chromosome
spreads of SW620 colon cancer cells and ABCG2+/ABCB5+ LESCs. (d) Cell cycle analysis of ABCG2+/ABCB5+ LESCs and LECs by
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ability to diﬀerentiate into corneal epithelial cells. Moreover,
the LESCs expressed high levels of the multipotent stem cell
markers Sox2, Oct4, c-Myc, and Klf4, displayed high telome-
rase activity, and were found to have a stable, normal
genome. These results suggest that our novel culture system
may be essential for long-term clinical success and stable
regeneration of corneal epithelia to treat corneal blindness
due to an LESC deﬁciency.
5. Conclusions
In summary, we described an improved cultivation protocol
using biopsies from the limbus, appropriate extracellular
matrices, and appropriate culture media to clonally expand
marker-speciﬁc-isolated stem cells and to subsequently
subcultivate highly proliferative cell colonies on a mixed
Matrigel and ﬁbronectic extracellular matrix in a deﬁned
environment to support the expansion and retention of stem
cells. Whether this culture technique enhances the therapeu-
tic potential of LESC transplantation remains to be evaluated.
Nevertheless, this culture system may represent a new start-
ing point for establishing a true stem cell-based therapy for
long-term ocular surface reconstruction. Moreover, for
extended survival of stem cells in a cultured graft, factors that
reproduce the niche environment must to be integrated into
the culture system in the future.
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